Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Gangnam Severance Hospital
This is an open-label, prospective, 1:1 randomized, parallel-group, study to evaluate the efficacy of expanded hemodialysis (HDx) compared to conventional hemodialysis in patients with chronic kidney disease in South Korea for up to 12 months.
Age
19–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
On HD treatment over 6 months before study enrollment
Aged over 18 years
Able to give informed consent
You may not be if
1. Hemiplegia or paraplegia state
2. Planned renal transplant or conversion to peritoneal dialysis within study period
3. Active chronic infection or inflammatory conditions including autoimmune disease, inflammatory arthritis and active malignancy
